Printer Friendly

FDA approves three St. Jude Medical devices.

Saint Paul, MN-based St. Jude Medical has been granted FDA approval for three of its medical devices: Current and Promote implantable defibrillators and the OptiSense pacing lead for pacemakers.

Current, an implantable cardioverter defibrillator, is designed to treat arrhythmia. Promote treats heart failure by synchronizing the beating of the ventricles, the company said. Both products include the ability to be reprogrammed quickly, and they contain technology that protects patients against shocks. In addition, these items can vibrate to alert patients to problems.

OptiSense is an insulated wire that enables pacemakers to receive a better read on signals from the right atrium of the heart. According to St. Jude, the device minimizes signals from the ventricles--an occurrence that has been shown to reduce a pacemaker's effectiveness.

COPYRIGHT 2007 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:TOP OF THE NEWS
Publication:Medical Product Outsourcing
Date:Jun 1, 2007
Words:125
Previous Article:Bush nominates new CMS administrator.
Next Article:Boston Scientific considers selling noncore assets.
Topics:


Related Articles
St. Jude Medical initiates patent litigation against Vascular Solutions.
Death due to malfunction of heart valve made by hospital: case on point: Enlow v. St. Jude Medical, Inc., No.3:00CV-666-S (W.D.Ky.10/18/2001) F. 3d...
ST. JUDE GETS FDA PRE-MARKET APPROVAL FOR EPIC DR ICD/VR ICD'S.
ST. JUDE MEDICAL REPORTS FIRST IMPLANT OF DEFIBRILLATION LEAD.
FDA grants Medtronic device approvals.
St. Jude gets IDE for deep brain stimulation to treat depression.
St. Jude expands.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters